A novel bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices

HL Paish, LH Reed, H Brown, MC Bryan, O Govaere, J Leslie, BS Barksby, J French, SA White, DM Manas, SM Robinson, G Spoletini, C Griffiths, Michael Drinnan, DA Mann, F Oakley

Research output: Working paperPreprint

Abstract

Objective Precision cut liver slices (PCLS) retain the structure and cellular composition of the native liver and represent an improved system to study liver fibrosis compared to two-dimensional mono or co-cultures. The objective of this study was to develop a bioreactor system to increase the healthy lifespan of PCLS and model fibrogenesis.

Design PCLS were generated from normal rat or human liver, or 4-week carbon tetrachloride-fibrotic rat liver and cultured in our patented bioreactor. PCLS function was quantified by albumin ELISA. Fibrosis was induced in PCLS by TGFβ1 and PDGFββ stimulation. Alk5 inhibitor therapy was used. Fibrosis was assessed by fibrogenic gene expression, Picrosirius Red and αSmooth Muscle Actin staining, hydroxyproline assay and collagen 1a1, fibronectin and hyaluronic acid ELISA.

Results Bioreactor cultured PCLS are viable, maintaining tissue structure and stable albumin secretion for up to 6 days under normoxic culture conditions. Conversely, standard static transwell cultured PCLS rapidly deteriorate and albumin secretion is significantly impaired by 48 hours. TGFβ1 and PDGFββ stimulation of rat or human PCLS induced fibrogenic gene expression, release of extracellular matrix proteins, activation of hepatic myofibroblasts and histological fibrosis. Fibrogenesis slowly progresses over 6-days in cultured fibrotic rat PCLS without exogenous challenge. Alk5 inhibitor limited fibrogenesis in both TGFβ1 and PDGFββ stimulated PCLS and fibrotic PCLS.

Conclusion We describe a new bioreactor technology which maintains functional PCLS cultures for 6 days. Bioreactor cultured PCLS can be successfully used to model fibrogenesis and demonstrate efficacy of an anti-fibrotic therapy.
Original languageEnglish
PublisherbioRxiv
DOIs
Publication statusPublished - May 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'A novel bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices'. Together they form a unique fingerprint.

Cite this